Befejeződött3. fázis
A study to compare efficacy, safety, and immune response of GME751 and EU-authorized Keytruda in adult participants with untreated metastatic lung cancer
Key facts
- Where
- A Coruna, Barcelona, Córdoba, Madrid, Málaga, Oviedo és Valencia, SpanyolországSee the 9 sites
- Phase
- 3. fázis
Where in Spanyolország
- Fundacion Centro Oncologico Regional De Galicia Jose Antonio Quiroga Y PineyroA Coruna, SpanyolországNo longer taking part
- Hospital Universitari Vall d'HebronBarcelona, SpanyolországNo longer taking part
- Micancer Center S.L.P.Barcelona, SpanyolországNo longer taking part
- Hospital Universitario Reina SofiaCórdoba, SpanyolországNo longer taking part
- Hospital Clínico San CarlosMadrid, SpanyolországNo longer taking part
- MD Anderson Cancer CenterMadrid, SpanyolországNo longer taking part
- Hospital Quironsalud MalagaMálaga, SpanyolországNo longer taking part
- Hospital Universitario Central De AsturiasOviedo, SpanyolországNo longer taking part
- Hospital Arnau de Vilanova de ValenciaValencia, SpanyolországNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- H e x a l AG
- Trial code
- EU 2023-506882-70-00
- Record updated
- 2025. november 3.